News OpenAI introduces GPT-Rosalind, its drug discovery AI In this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.
News Amazon joins the AI health assistant movement Amazon has become the latest tech company to introduce an AI-powered assistant designed to provide health guidance based on medical records.
News JPM: Anthropic reveals its answer to ChatGPT for Health Anthropic has launched Claude for Healthcare, a suite of AI tools designed for health systems, payers, and patients.
News OpenAI launches ChatGPT Health portal OpenAI unveils ChatGPT Health, which will link queries to medical records and health and wellness apps – if users are happy to share the data.
News ChatGPT can cut review times for clinical trial eligibility ChatGPT can't replace humans when it comes to checking patient eligibility to take part in clinical trials, but it can save time and money.
Digital From 0.1% to infinity: How increasingly larger GPT models ar... Using GPT can drastically increase the probability of success in the process of finding new molecules that can be used for drugs.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.